Article

Osteoporosis, More Costly Than You Think

An Argentinean Epidemiological Study on the Prevalence of Osteoporosis and the costs associated with the disease was highlighted at a press conference held by the International Osteoporosis Foundation Latin America regional office in Buenos Aires, Argentina.

An Argentinean Epidemiological Study on the Prevalence of Osteoporosis and the costs associated with the disease was highlighted at a press conference held by the International Osteoporosis Foundation Latin America regional office in Buenos Aires, Argentina.

Among the key findings were:

• In Argentina, bone mineral density studies reveal that one out of three women aged 50 or over suffers from osteoporosis.

• The prevalence of vertebral fractures in Argentinean women aged 50 or older is 16%.

• Over 34.000 hip fractures occur every year among the 50 years or older population, with an average of 90 fractures per day.

• The cost of vertebral and hip osteoporotic fractures is estimated in approximately 250 million dollars per year in Argentina.

• Risk factors for hip fracture include cognitive impairment, previous falls, low calcium intake during youth, vitamin D deficiency, advanced age, and current low calcium intake.

For more, check out this press release.

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.